Login / Register The Most Trusted Name in Medical Education

Pain Medicine

Improve your knowledge of pain management by taking Elsevier's complimentary pain medicine continuing medical education courses.

3 910727 Banner 116 x 140

In Focus: Advances in Non-Oral Modalities for the Treatment of Acute Migraine

Format: Live Meeting

Sunday, September 10, 2017
6:45 AM – 7:00 AM
On-site Check-in and Breakfast Buffet
7:00 AM – 8:00 AM CME Symposium
Vancouver Convention Centre East East Ballroom C,
Convention Level 999 Canada Place Vancouver, BC, Canada

Migraine treatment includes both preventive therapy, aimed at reducing attack frequency and severity, and acute therapy, for aborting attacks. For acute therapy, the most widely used drugs are NSAIDs and triptans. Routes of triptan administration include oral, intranasal, suppository, subcutaneous, and transdermal iontophoretic, as well as a variety of device-enhanced delivery options. Relatively slow onset of action remains a limitation for these formulations, except for the injectable delivery. Novel routes of delivery, such as intradermal, are in development, holding the promise of rapid absorption into the systemic circulation and, thus, rapid relief. Ultimately, the abundance of delivery options provides more choices to patients with migraine.

Register Now»

Credits: 1.0 AMA PRA Category 1 Credit™
910638 116 x 140

Strategies for Combating Opioid-Induced Constipation:Targeted Mechanisms to Maintain Pain Control Without Compromise

Format: Webcast

The content for this activity is based on the satellite symposium, “Strategies for Combating Opioid-Induced Constipation: Targeted Mechanisms to Maintain Pain Control Without Compromise” that was presented at the American Academy of Physical Medicine and Rehabilitation Annual Assembly (AAPM&R) on October 21, 2016.  Opioid-induced constipation (OIC) is a common side effect of opioid use and can occur from the outset of opioid therapy. OIC has been reported to interfere with pain management, increase health care costs, decrease work productivity and daily activities, and significantly affect patient quality of life. It can also lead to bowel obstruction. Assessing and managing OIC is important for establishing maximum function for patients. Several pharmacologic approaches, with different mechanisms of action, are available or in development.

Register »

Credits: 1.50 AMA PRA Category 1 Credit(s)™
910561 125 x 125

REMS Update 2017: Risk Evaluation and Mitigation Strategy

Format: Webcast

This educational supplement has been created to educate healthcare professionals on the safe and proper use of Extended-Release (ER) and Long-Acting (LA) opioids for chronic pain management. Opioids are the cornerstone of modern pain management. They are highly complex molecules which require knowledge and integration of basic science, clinical, pharmacological, psychosocial, abuse, diversion, and public health aspects of opioids. This Opioid Risk Evaluation and Mitigation Strategy (REMS) supplement is a valuable tool that can be utilized daily by everyone in your practice. Continuing Medical Education (CME/CE) credits are available for studying this supplement and completing the online test. The supplement and test can be completed in a little more than three hours, but it will have a lifetime benefit!

Take Course »

Credits: 3.00 AMA PRA Category 1 Credit(s)™ or 3.0 Nursing Contact Hours